Cancer BiologybioRxivPreprint
Caveolin-1 temporal modulation enhances trastuzumab and trastuzumab-drug conjugate efficacy in heterogeneous gastric cancer
P. M. R. Pereira, K. Mandleywala, S. Monette…·J. S. Lewis
This paper identifies CAV1 as a biomarker for trastuzumab efficacy in HER2-positive gastric cancer and shows that statin use enhances antibody therapy response.
DOI 10.1101/2021.07.13.452260